Table 1.
The association of HDAC7 expression with clinicopathological features in the TCGA cohort
| Characteristics | Low expression of HDAC7 | High expression of HDAC7 | P value |
|---|---|---|---|
| n | 115 | 122 | |
| Pathologic T stage, n (%) | 0.216 | ||
| T1 | 64 (27%) | 53 (22.4%) | |
| T2 | 24 (10.1%) | 28 (11.8%) | |
| T3 | 24 (10.1%) | 34 (14.3%) | |
| T4 | 3 (1.3%) | 7 (3%) | |
| Pathologic N stage, n (%) | 0.146 | ||
| N0 | 115 (48.5%) | 118 (49.8%) | |
| N1 | 0 (0%) | 4 (1.7%) | |
| Pathologic M stage, n (%) | 1.000 | ||
| M0 | 113 (47.7%) | 120 (50.6%) | |
| M1 | 2 (0.8%) | 2 (0.8%) | |
| Pathologic stage, n (%) | 0.119 | ||
| Stage I | 64 (27%) | 51 (21.5%) | |
| Stage II | 24 (10.1%) | 26 (11%) | |
| Stage III | 25 (10.5%) | 42 (17.7%) | |
| Stage IV | 2 (0.8%) | 3 (1.3%) | |
| Gender, n (%) | 0.053 | ||
| Female | 29 (12.2%) | 45 (19%) | |
| Male | 86 (36.3%) | 77 (32.5%) | |
| Age, n (%) | 0.006 | ||
| <= 60 | 53 (22.4%) | 78 (32.9%) | |
| > 60 | 62 (26.2%) | 44 (18.6%) | |
| Histologic grade, n (%) | 0.060 | ||
| G1 | 17 (7.2%) | 12 (5.1%) | |
| G2 | 57 (24.1%) | 46 (19.4%) | |
| G3 | 36 (15.2%) | 59 (24.9%) | |
| G4 | 5 (2.1%) | 5 (2.1%) |